CCM
DXCM icon

Coldstream Capital Management’s DexCom DXCM Stock Holding History

Coldstream Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$701K Buy
11,170
+5,332
+91% +$371K 0.01% 580
2025
Q4 		$387K Sell
5,838
-2,601
-31% -$168K 0.01% 816
2025
Q3 		$568K Sell
8,439
-125
-1% -$9.89K 0.01% 688
2025
Q2 		$748K Sell
8,564
-2,446
-22% -$192K 0.01% 499
2025
Q1 		$752K Sell
11,010
-2,105
-16% -$172K 0.02% 447
2024
Q4 		$1.02M Buy
13,115
+1,862
+17% +$138K 0.02% 377
2024
Q3 		$781K Buy
11,253
+3,508
+45% +$288K 0.02% 451
2024
Q2 		$878K Buy
7,745
+1,274
+20% +$161K 0.02% 355
2024
Q1 		$898K Buy
6,471
+336
+5% +$42.2K 0.02% 351
2023
Q4 		$761K Buy
6,135
+1,660
+37% +$170K 0.02% 361
2023
Q3 		$418K Sell
4,475
-998
-18% -$113K 0.01% 501
2023
Q2 		$703K Buy
5,473
+4
+0.1% +$484 0.02% 340
2023
Q1 		$635K Sell
5,469
-17
-0.3% -$1.9K 0.02% 364
2022
Q4 		$621K Buy
+5,486
New +$602K 0.02% 363
2022
Q2 		$281K Buy
3,768
+788
+26% +$71.9K 0.01% 587
2022
Q1 		$381K Sell
2,980
-736
-20% -$80.5K 0.01% 475
2021
Q4 		$499K Buy
+3,716
New +$534K 0.02% 427

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Coldstream Capital Management's DXCM Position: Q1 2026 in Review

Coldstream Capital Management increased its DexCom (DXCM) stake by 91% in Q1 2026, buying an estimated $371K and bringing the position to 11,170 shares worth $701K. The position accounts for 0.01% of the portfolio, ranked #580.

Coldstream Capital Management first reported a position in DXCM in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.02M in Q4 2024. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Coldstream Capital Management held 11,170 shares of DexCom worth $701K as of Q1 2026.
  • Coldstream Capital Management bought 5,332 DexCom shares in Q1 2026, an estimated $371K.
  • DexCom made up 0.01% of Coldstream Capital Management's portfolio in Q1 2026, its #580 holding.
  • Coldstream Capital Management first reported a position in DexCom in Q4 2021 and has held it in 17 quarters since.
  • Coldstream Capital Management's DexCom position peaked at $1.02M in Q4 2024.
  • 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.